Description: A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to

Description: Waters Corporation has lagged the broader market over the past year, yet analysts still see a steady path forward, maintaining a moderately upbeat outlook on the company’s long-term prospects.

Description: Waters Corporation recently reported its third quarter results for 2025, showing revenue of US$799.89 million and net income of US$148.92 million, while also raising both its fourth quarter and full-year sales and earnings guidance. This announcement combined stronger year-to-date financial performance with increased management confidence, as reflected by the updated earnings outlook for the remainder of 2025. Given the upward revision of full-year guidance and ongoing revenue growth, we'll...

Description: Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, 2025, at 2:30 PM Greenwich Mean Time (9:30 AM Eastern Time).

Description: Waters Corporation (NYSE:WAT) today announced the launch of its Charged Aerosol Detector (CAD) specifically designed for use with Waters Empower Software, the world's most trusted chromatography data system (CDS). Waters is the global market leader in chromatography software solutions for regulatory filings, as Empower Software is used to submit data for approximately 80% of novel drugs to regulatory authorities.2

Description: Investing.com -- Becton Dickinson posted fourth-quarter earnings that came in slightly above expectations and offered guidance that also beat forecasts.

Description: Waters (WAT) posted annual revenue growth of 14.5% and earnings per share are forecast to expand by 15.2% per year, just below the US market average. Over the past year, earnings ticked up 4.3%, and net profit margins landed at 20.9%, a slight dip from 21.4% a year ago. Investors are weighing ongoing profit and revenue growth against a share price that trades above fair value, as margins have compressed slightly. See our full analysis for Waters. The next section takes these results and puts...

Description: WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.

Description: Waters Corp (WAT) reports an 8% revenue increase and raises full-year guidance, driven by robust instrument and recurring sales growth.

Description: Shares of scientific instruments company Waters Corporation (NYSE:WAT) jumped 8.2% in the morning session after it reported mixed third-quarter 2025 results where a strong revenue performance outweighed a miss on profitability. The company announced sales of $799.9 million, up 8% year on year and beating Wall Street estimates by 2.4%. This top-line strength was driven by an 8% increase in organic revenue, which also surpassed expectations. However, the quarter was not without its challenges. Wat

Description: Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]

Description: Waters (WAT) delivered earnings and revenue surprises of +5.92% and +2.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Scientific instruments company Waters Corporation (NYSE:WAT) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 8% year on year to $799.9 million. The company expects next quarter’s revenue to be around $926.8 million, close to analysts’ estimates. Its GAAP profit of $2.50 per share was 14.7% below analysts’ consensus estimates.

Description: The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $3.21 per share. The maker of products used in drug discovery and development posted revenue of $799.9 million in the period, also topping Street forecasts.

Description: Waters Corporation (NYSE: WAT), today announced its financial results for the third quarter of 2025.

Description: Waters (WAT) stock has shown some interesting price movement over the past month, up nearly 6% even as long-term returns remain mixed. Investors may be weighing recent business results and overall sector sentiment at current levels. See our latest analysis for Waters. Waters’ share price has bounced back impressively in the last month with a 6.5% gain, though its 1-year total shareholder return remains negative. Momentum is picking up after a 22% share price rise over the past 90 days, which...

Description: Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Waters Corporation is all set to unveil its fiscal third-quarter earnings next month, and analysts project a high single-digit earnings growth.

Description: Solventum (NYSE: SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson.

Description: Earlier this month, Waters Corporation launched the Xevo Charge Detection Mass Spectrometer (CDMS), offering direct, individual-particle mass measurement of mega-mass biomolecules critical to next-generation therapeutics and structural biology. This innovation enables scientists to analyze complex biomolecules, such as viral vectors and mRNA therapeutics, using up to 100-fold less sample volume and delivering results in under ten minutes, addressing major industry challenges in advanced...

Description: Trying to decide what to do with Waters stock? You're not alone. Whether you’ve already got a stake or are looking for an open lane, recent moves in the share price have sparked plenty of conversation. After a lukewarm year so far, with the stock down 9.1% year to date, Waters just pulled off a strong 10.2% rally over the past month, following a more modest 1.1% gain last week. That kind of reversal always catches the eye, especially for a company that has managed to post an 18.6% return over...

Description: While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.